» Articles » PMID: 28598223

Mitochondria in Chronic Obstructive Pulmonary Disease and Lung Cancer: Where Are We Now?

Overview
Journal Biomark Med
Date 2017 Jun 10
PMID 28598223
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Recent advances in mitochondrial biogenesis have provided the emerging recognition that mitochondria do much more than 'simply providing energy for cellular function'. Currently, a constantly improving understanding of the mitochondrial structure and function has been providing valuable insights into the contribution of defects in mitochondrial metabolism to various human diseases, including chronic obstructive pulmonary disease and lung cancer. The growing interest in mitochondria research led to development of new biomedical fields in the two main smoking-related lung diseases. However, there is considerable paucity in our understanding of mechanisms by which mitochondrial dynamics regulate lung diseases. In this review, we will discuss our current knowledge on the role of mitochondrial dysfunction in the pathogenesis of chronic obstructive pulmonary disease and non-small-cell lung cancer.

Citing Articles

MicroRNAs as promising drug delivery target to ameliorate chronic obstructive pulmonary disease using nano-carriers: a comprehensive review.

Khanna V, Singh K Mol Cell Biochem. 2024; 480(3):1431-1448.

PMID: 39254870 DOI: 10.1007/s11010-024-05110-0.


NADH Intraperitoneal Injection Prevents Lung Inflammation in a BALB/C Mice Model of Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease.

Slama N, Abdellatif A, Bahria K, Gasmi S, Khames M, Hadji A Cells. 2024; 13(10.

PMID: 38786103 PMC: 11120028. DOI: 10.3390/cells13100881.


Mitochondrial Dysfunction in Chronic Obstructive Pulmonary Disease: Unraveling the Molecular Nexus.

Li C, Liu J, Liu S Biomedicines. 2024; 12(4).

PMID: 38672169 PMC: 11048013. DOI: 10.3390/biomedicines12040814.


T Intratracheal Therapy Alleviates Pulmonary Pathology in an Elastase-Induced Emphysema-Dominant COPD Mouse Model.

Takahashi N, Nakashima R, Nasu A, Hayashi M, Fujikawa H, Kawakami T Antioxidants (Basel). 2024; 13(1).

PMID: 38247455 PMC: 10812479. DOI: 10.3390/antiox13010030.


Comprehensive analysis the prognostic and immune characteristics of mitochondrial transport-related gene SFXN1 in lung adenocarcinoma.

Liu W, Du Q, Mei T, Wang J, Huang D, Qin T BMC Cancer. 2024; 24(1):94.

PMID: 38233752 PMC: 10795352. DOI: 10.1186/s12885-023-11646-z.


References
1.
Adcock I, Caramori G, Barnes P . Chronic obstructive pulmonary disease and lung cancer: new molecular insights. Respiration. 2011; 81(4):265-84. DOI: 10.1159/000324601. View

2.
Luft R, IKKOS D, Palmieri G, Ernster L, AFZELIUS B . A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical, and morphological study. J Clin Invest. 1962; 41:1776-804. PMC: 291101. DOI: 10.1172/JCI104637. View

3.
Hosgood 3rd H, Liu C, Rothman N, Weinstein S, Bonner M, Shen M . Mitochondrial DNA copy number and lung cancer risk in a prospective cohort study. Carcinogenesis. 2010; 31(5):847-9. PMC: 2864414. DOI: 10.1093/carcin/bgq045. View

4.
Warburg O . On the origin of cancer cells. Science. 1956; 123(3191):309-14. DOI: 10.1126/science.123.3191.309. View

5.
Anderson S, Bankier A, Barrell B, de Bruijn M, Coulson A, Drouin J . Sequence and organization of the human mitochondrial genome. Nature. 1981; 290(5806):457-65. DOI: 10.1038/290457a0. View